...
首页> 外文期刊>Mycoses: Diagnosis, therapy and prophylaxis of fungal diseases >Comparison of fks fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata Candida glabrata resistance to micafungin: A systematic review and meta‐analysis
【24h】

Comparison of fks fks gene mutations and minimum inhibitory concentrations for the detection of Candida glabrata Candida glabrata resistance to micafungin: A systematic review and meta‐analysis

机译:FKS FKS基因突变比较和最小抑制浓度检测米非芬念珠菌念珠菌念珠菌的抗性:系统评价和荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Candida resistance to antifungals impaired invasive candidiasis outcome. In a context of echinocandin resistance development, we aimed to evaluate the association between phenotypic resistance to micafungin and fks mutations of Candida glabrata . For this systematic review and meta‐analysis, we searched MEDLINE, Scopus and Web of Science for reports published up to December 2017. Studies of C?glabrata candidiasis with minimum inhibitory concentrations (MIC) determination of micafungin and fks genotyping were included. Reviews, studies not using reference methods, non‐ glabrata Candida , experimental isolates and undetailed mutations were excluded. Two authors independently assessed the eligibility of articles and extracted data. The main outcome was the diagnostic accuracy of fks mutations compared to micafungin MIC for C?glabrata , measured as fixed‐effect odd ratio. Heterogeneity was calculated with the I 2 statistic. This study is registered with PROSPERO (CRD42018082023). Twenty‐four studies were included in the meta‐analysis. Pooled analysis found that S663P (OR 7.25, 95% CI 3.50‐15.00; P ??0.00001), S629P (OR 3.70, 1.64‐8.33; P ?=?0.002) and F659del (OR 5.66, 1.22‐26.18; P ?=?0.03) were associated with increased risk of having a resistant isolate according to authors' interpretation of MICs. In sensitivity analysis based on new CLSI clinical breakpoints, the ORs for S663P and S629P remained significant. Genotyping of isolates of C?glabrata for S663P and S629P mutations is an effective alternative to micafungin susceptibility tests. Relevant molecular markers of drug resistance will significantly improve the management of C?glabrata infections.
机译:总结念珠菌抗抗菌患者患者候选念珠菌病的结果。在Echinocandinin抗性发育的背景下,我们旨在评估对Micafungin的表型抗性与Candida Glabrata的FKS突变之间的关联。对于此系统审查和荟萃分析,我们搜索了2017年12月发布的报告的Medline,Scopus和Science Web. C?含有最小抑制浓度(MIC)Micafungin和FKS基因分型的Glabrata念珠菌病的研究。除了使用参考方法的研究,非Glabrata念珠菌,实验分离株和未被释放的突变的评论。两位作者独立评估文章的资格和提取数据。主要结果是FKS突变的诊断准确性与Michrata的MiCafungin MIC相比,以固定效应奇数比率测量。用I 2统计计算异质性。本研究在Prospero注册(CRD42018082023)。在Meta分析中包含二十四项研究。汇总分析发现S663P(或7.25,95%CI 350-15.00; P?&?0.00001),S629p(或3.70,1.64-8.33; p?= 0.002)和f659del(或5.66,1.22-26.18; p ?=?0.03)与根据作者对MIC的解释具有抗性孤立的风险增加。在基于新的CLSI临床分接点的敏感性分析中,S663P和S629P的ORS仍然显着。 S663P和S629P突变的C 2的分离株的基因分型是Micafungin易感测试的有效替代品。相关分子标记的耐药性将显着改善C?Glabrata感染的管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号